← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2019Last known activity
Aug 29, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (24 distinct, 20 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (9 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Recent trials (42)
- NCT07261306Sponsor investigatorEarly Phase 1Aug 29, 2025
- NCT07261306Lead sponsorEarly Phase 1Aug 29, 2025
- NCT07261306OfficialEarly Phase 1Aug 29, 2025
- NCT06915688Sponsor investigatorN/AApr 15, 2025
- NCT06915688Lead sponsorN/AApr 15, 2025
- NCT06880042Sponsor investigatorEarly Phase 1Mar 11, 2025
- NCT06880042Lead sponsorEarly Phase 1Mar 11, 2025
- NCT07044141Lead sponsorPhase 1Mar 1, 2025
- NCT07044141Sponsor investigatorPhase 1Mar 1, 2025
- NCT06847204Sponsor investigatorPhase 1/Phase 2Feb 24, 2025
- NCT06847204Lead sponsorPhase 1/Phase 2Feb 24, 2025
- NCT06889909Sponsor investigatorN/ADec 15, 2024
- NCT06889909Lead sponsorN/ADec 15, 2024
- NCT06889909OfficialN/ADec 15, 2024
- NCT06838104OfficialN/ADec 5, 2024
Details
- Last known activity
- Aug 29, 2025